Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable
- 1 June 2020
- journal article
- letter
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 147, 217-220
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York CityAnnals of Oncology, 2020
- Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in CaliforniaJAMA, 2020
- Is low dose radiation therapy a potential treatment for COVID-19 pneumonia?Radiotherapy and Oncology, 2020
- Universal Screening for SARS-CoV-2 in Women Admitted for DeliveryNew England Journal of Medicine, 2020
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020
- Covid-19 in Critically Ill Patients in the Seattle Region — Case SeriesNew England Journal of Medicine, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, ItalyJAMA, 2020
- Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast CancerNew England Journal of Medicine, 2013
- Systematic Review and Meta-analysis of Circulatory Disease from Exposure to Low-Level Ionizing Radiation and Estimates of Potential Population Mortality RisksEnvironmental Health Perspectives, 2012